Nilvadipine
CAS No. 75530-68-6
Nilvadipine ( CL 287,389 | FK-235 | FR34235 | (±)-Nilvadipine | SKF 102362 )
产品货号. M15873 CAS No. 75530-68-6
Nilvadipine 是一种钙通道阻滞剂 (CCB),用于治疗高血压。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥145 | 有现货 |
|
| 10MG | ¥240 | 有现货 |
|
| 25MG | ¥274 | 有现货 |
|
| 50MG | ¥323 | 有现货 |
|
| 100MG | ¥537 | 有现货 |
|
| 500MG | ¥1701 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥263 | 有现货 |
|
生物学信息
-
产品名称Nilvadipine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Nilvadipine 是一种钙通道阻滞剂 (CCB),用于治疗高血压。
-
产品描述Nilvadipine is a calcium channel blocker (CCB) for treatment of hypertension.(In Vitro):In an in vitro experiment on inhibition of migration of rat aortic smooth muscle cells, using Zymosan-activated air pouch exudate as a chemoattractant in modified Boyden chambers.The IC50 value is 0.033 nM for Nilvadipine (FR34235). Effects of Nilvadipine on proliferation of rat aortic smooth muscle cells and rabbit platelet aggregation is also examined. Nilvadipine should be useful for preventing and treating atherosclerosis. Inhibition of smooth muscle cell migration is thought to be its mechanism of antiatherogenic activity. The antioxidant effect of calcium antagonist Nilvadipine is studied by means of rat myocardial membrane lipid peroxidation with a nonenzymatic active oxygen-generating system (DHF/FeC13-ADP) with IC50 of 25.1 μM. Nilvadipine shows antioxidant effects both before and after the addition of active oxygen, and reduces the dihydroxyfumarate (DHF) auto-oxidation rate, is chain-breaking and preventive antioxidants. Nicardipine, which shows an antioxidant effect only before exposure to active oxygen and reduced the DHF auto-oxidation rate, is mainly a preventive antioxidant. (In Vivo):The antiatherogenic activity of Nilvadipine (FR34235), a calcium antagonist, is examined in rabbits with carotid arteries sheathed with polyethylene cuffs, and compared with that of Nifedipine, Verapamil and Diltiazem. Nilvadipine is given intramuscularly in daily doses of 0.01-10 mg/kg for 3 weeks, starting on the day of cuff-placement. FR34235 dose-dependently inhibits the cuff-induced intimal thickening. Nilvadipine affords significant protection against thinning of retinal layers in the RCS rat during retinal degeneration. Electron microscopy shows that marked irregularity in the photoreceptor OS in the untreated retina.
-
体外实验In an in vitro experiment on inhibition of migration of rat aortic smooth muscle cells, using Zymosan-activated air pouch exudate as a chemoattractant in modified Boyden chambers.The IC50 value is 0.033 nM for Nilvadipine (FR34235). Effects of Nilvadipine on proliferation of rat aortic smooth muscle cells and rabbit platelet aggregation is also examined. Nilvadipine should be useful for preventing and treating atherosclerosis. Inhibition of smooth muscle cell migration is thought to be its mechanism of antiatherogenic activity. The antioxidant effect of calcium antagonist Nilvadipine is studied by means of rat myocardial membrane lipid peroxidation with a nonenzymatic active oxygen-generating system (DHF/FeC13-ADP) with IC50 of 25.1 μM. Nilvadipine shows antioxidant effects both before and after the addition of active oxygen, and reduces the dihydroxyfumarate (DHF) auto-oxidation rate, is chain-breaking and preventive antioxidants. Nicardipine, which shows an antioxidant effect only before exposure to active oxygen and reduced the DHF auto-oxidation rate, is mainly a preventive antioxidant.
-
体内实验The antiatherogenic activity of Nilvadipine (FR34235), a calcium antagonist, is examined in rabbits with carotid arteries sheathed with polyethylene cuffs, and compared with that of Nifedipine, Verapamil and Diltiazem. Nilvadipine is given intramuscularly in daily doses of 0.01-10 mg/kg for 3 weeks, starting on the day of cuff-placement. FR34235 dose-dependently inhibits the cuff-induced intimal thickening. Nilvadipine affords significant protection against thinning of retinal layers in the RCS rat during retinal degeneration. Electron microscopy shows that marked irregularity in the photoreceptor OS in the untreated retina.
-
同义词CL 287,389 | FK-235 | FR34235 | (±)-Nilvadipine | SKF 102362
-
通路GPCR/G Protein
-
靶点Calcium Channel
-
受体Calcium Channel
-
研究领域Cardiovascular Disease
-
适应症——
化学信息
-
CAS Number75530-68-6
-
分子量385.38
-
分子式C19H19N3O6
-
纯度>98% (HPLC)
-
溶解度Ethanol: 33 mg/mL (85.63 mM); DMSO: 77 mg/mL (199.8 mM)
-
SMILESCC1=C(C(OC(C)C)=O)C(C2=CC([N+]([O-])=O)=CC=C2)C(C(OC)=O)=C(C#N)N1
-
化学全称5-isopropyl 3-methyl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Nomoto A, et al. Atherosclerosis, 1988, 72(2-3), 213-219.
产品手册
关联产品
-
alpha-L-Rhamnose
将富含鼠李糖的多糖 RROP-1 添加到正常人真皮成纤维细胞 (NHDF) 和人内皮细胞中,对钙信号通路产生剂量依赖性刺激,诱导 Ca2 流入和细胞内游离 Ca2 水平快速且短暂的增加。
-
McN5691
McN5691 是一种电压依赖性钙通道 (calcium channel) 阻滞剂。
-
DS16570511
DS16570511 是线粒体钙单抗体的细胞渗透抑制剂,可阻断 MCU 或 MICU1 依赖性 Ca2+ 内流。DS16570511 对 HEK293A 细胞中血清诱导的线粒体 Ca2+ 内流具有剂量依赖性抑制作用,IC50 为 7 M。DS16570511 抑制分离 Ca2+ 的摄取。来自人体细胞、大鼠心脏和猪心脏的线粒体。
021-51111890
购物车()
sales@molnova.cn

